What is cancer detection? Cancer detection using Artificial Intelligence (AI) involves leveraging advanced machine learning algorithms and techniques to identify and diagnose cancer from various medical data sources. The goal is to enhance early detection, improve diagnostic accuracy, and potentially reduce the need for invasive procedures.
Papers and Code
Jan 29, 2025
Abstract:Automated diagnostic systems (ADS) have shown significant potential in the early detection of polyps during endoscopic examinations, thereby reducing the incidence of colorectal cancer. However, due to high annotation costs and strict privacy concerns, acquiring high-quality endoscopic images poses a considerable challenge in the development of ADS. Despite recent advancements in generating synthetic images for dataset expansion, existing endoscopic image generation algorithms failed to accurately generate the details of polyp boundary regions and typically required medical priors to specify plausible locations and shapes of polyps, which limited the realism and diversity of the generated images. To address these limitations, we present Polyp-Gen, the first full-automatic diffusion-based endoscopic image generation framework. Specifically, we devise a spatial-aware diffusion training scheme with a lesion-guided loss to enhance the structural context of polyp boundary regions. Moreover, to capture medical priors for the localization of potential polyp areas, we introduce a hierarchical retrieval-based sampling strategy to match similar fine-grained spatial features. In this way, our Polyp-Gen can generate realistic and diverse endoscopic images for building reliable ADS. Extensive experiments demonstrate the state-of-the-art generation quality, and the synthetic images can improve the downstream polyp detection task. Additionally, our Polyp-Gen has shown remarkable zero-shot generalizability on other datasets. The source code is available at https://github.com/CUHK-AIM-Group/Polyp-Gen.
* Accepted by ICRA 2025
Via

Jan 15, 2025
Abstract:Colorectal cancer (CRC) is one of the most commonly diagnosed cancers all over the world. It starts as a polyp in the inner lining of the colon. To prevent CRC, early polyp detection is required. Colonosopy is used for the inspection of the colon. Generally, the images taken by the camera placed at the tip of the endoscope are analyzed by the experts manually. Various traditional machine learning models have been used with the rise of machine learning. Recently, deep learning models have shown more effectiveness in polyp detection due to their superiority in generalizing and learning small features. These deep learning models for object detection can be segregated into two different types: single-stage and two-stage. Generally, two stage models have higher accuracy than single stage ones but the single stage models have low inference time. Hence, single stage models are easy to use for quick object detection. YOLO is one of the singlestage models used successfully for polyp detection. It has drawn the attention of researchers because of its lower inference time. The researchers have used Different versions of YOLO so far, and with each newer version, the accuracy of the model is increasing. This paper aims to see the effectiveness of the recently released YOLOv11 to detect polyp. We analyzed the performance for all five models of YOLOv11 (YOLO11n, YOLO11s, YOLO11m, YOLO11l, YOLO11x) with Kvasir dataset for the training and testing. Two different versions of the dataset were used. The first consisted of the original dataset, and the other was created using augmentation techniques. The performance of all the models with these two versions of the dataset have been analysed.
Via

Jan 01, 2025
Abstract:Oral cancer constitutes a significant global health concern, resulting in 277,484 fatalities in 2023, with the highest prevalence observed in low- and middle-income nations. Facilitating automation in the detection of possibly malignant and malignant lesions in the oral cavity could result in cost-effective and early disease diagnosis. Establishing an extensive repository of meticulously annotated oral lesions is essential. In this research photos are being collected from global clinical experts, who have been equipped with an annotation tool to generate comprehensive labelling. This research presents a novel approach for integrating bounding box annotations from various doctors. Additionally, Deep Belief Network combined with CAPSNET is employed to develop automated systems that extracted intricate patterns to address this challenging problem. This study evaluated two deep learning-based computer vision methodologies for the automated detection and classification of oral lesions to facilitate the early detection of oral cancer: image classification utilizing CAPSNET. Image classification attained an F1 score of 94.23% for detecting photos with lesions 93.46% for identifying images necessitating referral. Object detection attained an F1 score of 89.34% for identifying lesions for referral. Subsequent performances are documented about classification based on the sort of referral decision. Our preliminary findings indicate that deep learning possesses the capability to address this complex problem.
* Accepted to IEEE International Conference on Advancement in
Communication and Computing Technology (INOACC), will be held in Sai Vidya
Institute of Technology, Bengaluru, Karnataka, India. (Preprint)
Via

Dec 14, 2024
Abstract:Prostate cancer is a leading cause of cancer-related deaths among men. The recent development of high frequency, micro-ultrasound imaging offers improved resolution compared to conventional ultrasound and potentially a better ability to differentiate clinically significant cancer from normal tissue. However, the features of prostate cancer remain subtle, with ambiguous borders with normal tissue and large variations in appearance, making it challenging for both machine learning and humans to localize it on micro-ultrasound images. We propose a novel Mask Enhanced Deeply-supervised Micro-US network, termed MedMusNet, to automatically and more accurately segment prostate cancer to be used as potential targets for biopsy procedures. MedMusNet leverages predicted masks of prostate cancer to enforce the learned features layer-wisely within the network, reducing the influence of noise and improving overall consistency across frames. MedMusNet successfully detected 76% of clinically significant cancer with a Dice Similarity Coefficient of 0.365, significantly outperforming the baseline Swin-M2F in specificity and accuracy (Wilcoxon test, Bonferroni correction, p-value<0.05). While the lesion-level and patient-level analyses showed improved performance compared to human experts and different baseline, the improvements did not reach statistical significance, likely on account of the small cohort. We have presented a novel approach to automatically detect and segment clinically significant prostate cancer on B-mode micro-ultrasound images. Our MedMusNet model outperformed other models, surpassing even human experts. These preliminary results suggest the potential for aiding urologists in prostate cancer diagnosis via biopsy and treatment decision-making.
Via

Dec 20, 2024
Abstract:Cases of laryngeal cancer are predicted to rise significantly in the coming years. Current diagnostic pathways cause many patients to be incorrectly referred to urgent suspected cancer pathways, putting undue stress on both patients and the medical system. Artificial intelligence offers a promising solution by enabling non-invasive detection of laryngeal cancer from patient speech, which could help prioritise referrals more effectively and reduce inappropriate referrals of non-cancer patients. To realise this potential, open science is crucial. A major barrier in this field is the lack of open-source datasets and reproducible benchmarks, forcing researchers to start from scratch. Our work addresses this challenge by introducing a benchmark suite comprising 36 models trained and evaluated on open-source datasets. These models are accessible in a public repository, providing a foundation for future research. They evaluate three different algorithms and three audio feature sets, offering a comprehensive benchmarking framework. We propose standardised metrics and evaluation methodologies to ensure consistent and comparable results across future studies. The presented models include both audio-only inputs and multimodal inputs that incorporate demographic and symptom data, enabling their application to datasets with diverse patient information. By providing these benchmarks, future researchers can evaluate their datasets, refine the models, and use them as a foundation for more advanced approaches. This work aims to provide a baseline for establishing reproducible benchmarks, enabling researchers to compare new methods against these standards and ultimately advancing the development of AI tools for detecting laryngeal cancer.
* 24 pages, 6 figures, 7 tables
Via

Dec 23, 2024
Abstract:This research presents an innovative approach to cancer diagnosis and prediction using explainable Artificial Intelligence (XAI) and deep learning techniques. With cancer causing nearly 10 million deaths globally in 2020, early and accurate diagnosis is crucial. Traditional methods often face challenges in cost, accuracy, and efficiency. Our study develops an AI model that provides precise outcomes and clear insights into its decision-making process, addressing the "black box" problem of deep learning models. By employing XAI techniques, we enhance interpretability and transparency, building trust among healthcare professionals and patients. Our approach leverages neural networks to analyse extensive datasets, identifying patterns for cancer detection. This model has the potential to revolutionise diagnosis by improving accuracy, accessibility, and clarity in medical decision-making, possibly leading to earlier detection and more personalised treatment strategies. Furthermore, it could democratise access to high-quality diagnostics, particularly in resource-limited settings, contributing to global health equity. The model's applications extend beyond cancer diagnosis, potentially transforming various aspects of medical decision-making and saving millions of lives worldwide.
Via

Dec 28, 2024
Abstract:Quantitative tools are increasingly appealing for decision support in healthcare, driven by the growing capabilities of advanced AI systems. However, understanding the predictive uncertainties surrounding a tool's output is crucial for decision-makers to ensure reliable and transparent decisions. In this paper, we present a case study on pulmonary nodule detection for lung cancer screening, enhancing an advanced detection model with an uncertainty quantification technique called conformal risk control (CRC). We demonstrate that prediction sets with conformal guarantees are attractive measures of predictive uncertainty in the safety-critical healthcare domain, allowing end-users to achieve arbitrary validity by trading off false positives and providing formal statistical guarantees on model performance. Among ground-truth nodules annotated by at least three radiologists, our model achieves a sensitivity that is competitive with that generally achieved by individual radiologists, with a slight increase in false positives. Furthermore, we illustrate the risks of using off-the-shelve prediction models when faced with ontological uncertainty, such as when radiologists disagree on what constitutes the ground truth on pulmonary nodules.
Via

Jan 26, 2025
Abstract:Fiducial marker positions in projection image of cone-beam computed tomography (CBCT) scans have been studied to evaluate daily residual motion during breath-hold radiation therapy. Fiducial marker migration posed challenges in accurately locating markers, prompting the development of a novel algorithm that reconstructs volumetric probability maps of marker locations from filtered gradient maps of projections. This guides the development of a Python-based algorithm to detect fiducial markers in projection images using Meta AI's Segment Anything Model 2 (SAM 2). Retrospective data from a pancreatic cancer patient with two fiducial markers were analyzed. The three-dimensional (3D) marker positions from simulation computed tomography (CT) were compared to those reconstructed from CBCT images, revealing a decrease in relative distances between markers over time. Fiducial markers were successfully detected in 2777 out of 2786 projection frames. The average standard deviation of superior-inferior (SI) marker positions was 0.56 mm per breath-hold, with differences in average SI positions between two breath-holds in the same scan reaching up to 5.2 mm, and a gap of up to 7.3 mm between the end of the first and beginning of the second breath-hold. 3D marker positions were calculated using projection positions and confirmed marker migration. This method effectively calculates marker probability volume and enables accurate fiducial marker tracking during treatment without requiring any specialized equipment, additional radiation doses, or manual initialization and labeling. It has significant potential for automatically assessing daily residual motion to adjust planning margins, functioning as an adaptive radiation therapy tool.
* 14 pages, 9 figures, Regeneron STS 2025 project. Project page:
https://sites.google.com/view/markertrack?usp=sharing
Via

Jan 12, 2025
Abstract:As deep learning models gain attraction in medical data, ensuring transparent and trustworthy decision-making is essential. In skin cancer diagnosis, while advancements in lesion detection and classification have improved accuracy, the black-box nature of these methods poses challenges in understanding their decision processes, leading to trust issues among physicians. This study leverages the CLIP (Contrastive Language-Image Pretraining) model, trained on different skin lesion datasets, to capture meaningful relationships between visual features and diagnostic criteria terms. To further enhance transparency, we propose a method called MedGrad E-CLIP, which builds on gradient-based E-CLIP by incorporating a weighted entropy mechanism designed for complex medical imaging like skin lesions. This approach highlights critical image regions linked to specific diagnostic descriptions. The developed integrated pipeline not only classifies skin lesions by matching corresponding descriptions but also adds an essential layer of explainability developed especially for medical data. By visually explaining how different features in an image relates to diagnostic criteria, this approach demonstrates the potential of advanced vision-language models in medical image analysis, ultimately improving transparency, robustness, and trust in AI-driven diagnostic systems.
* Accepted to 2025 IEEE/CVF Winter Conference on Applications of
Computer Vision Workshops (WACVW)
Via

Jan 27, 2025
Abstract:This study explores a data-driven approach to discovering novel clinical and genetic markers in ovarian cancer (OC). Two main analyses were performed: (1) a nonlinear examination of an OC dataset using autoencoders, which compress data into a 3-dimensional latent space to detect potential intrinsic separability between platinum-sensitive and platinum-resistant groups; and (2) an adaptation of the informative variable identifier (IVI) to determine which features (clinical or genetic) are most relevant to disease progression. In the autoencoder analysis, a clearer pattern emerged when using clinical features and the combination of clinical and genetic data, indicating that disease progression groups can be distinguished more effectively after supervised fine tuning. For genetic data alone, this separability was less apparent but became more pronounced with a supervised approach. Using the IVI-based feature selection, key clinical variables (such as type of surgery and neoadjuvant chemotherapy) and certain gene mutations showed strong relevance, along with low-risk genetic factors. These findings highlight the strength of combining machine learning tools (autoencoders) with feature selection methods (IVI) to gain insights into ovarian cancer progression. They also underscore the potential for identifying new biomarkers that integrate clinical and genomic indicators, ultimately contributing to improved patient stratification and personalized treatment strategies.
Via
